Purchases and Sales Made in Q3 2023 in Outlook Therapeutics, Inc. (OTLK)
This table provides information about the institutional ownership of Outlook Therapeutics, Inc. (OTLK) during Q3 2023. The information is specifically focused on institutions that hold shares of Outlook Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 09, 2023
Q3 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-53.2K- 83.8% |
$10.6K - $94.7K
|
10.3K
$13.6K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-56.2K- 27.93% |
$11.2K - $100K
|
145K
$191K
|
|
|
Nov 08, 2023
Q3 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-62.5K- 14.98% |
$12.5K - $111K
|
355K
$468K
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-71.4K- 53.83% |
$14.3K - $127K
|
61.2K
$80.8K
|
|
|
Nov 14, 2023
Q3 2023
|
Ancora Advisors, LLC
Cleveland, OH |
SELL
|
- |
-86.5K- 79.72% |
$17.3K - $154K
|
22K
$29K
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-172K- 84.83% |
$34.5K - $307K
|
30.8K
$40.7K
|